Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Jubilant HollisterStier Wins Four Contracts | Contract Pharma

What are you searching for?

Sign in
Breaking News

Jubilant HollisterStier Wins Four Contracts

Will manufacture sterile parenteral products at Spokane facility

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Jubilant HollisterStier’s Contract Manufacturing & Services division has won contracts with four innovator life science companies for the commercial manufacture of sterile parenteral products for sale in the U.S. and Europe. The company will manufacture the products, which range from liquid to lyophilization presentations, at its Spokane, WA facility. The contracts are valued at more than $90 million and will be executed during a period of five years.

“We have successfully helped provide safe and effective products to innovator pharmaceutical and biotechnology companies over the years and are committed to do so for these products as well. We are pleased to offer our support in the development and manufacture of highly complex products through the application of leading scientific solutions and utmost dedication to quality and customer service. This expansion of our globally leading parenteral manufacturing capabilities is a further outcome of our strategy to extend our offering across products and geographies.” said Marcelo Morales, chief executive officer, Jubilant HollisterStier.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics